TY - JOUR
T1 - Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung Tumors
AU - Ahmadsei, Maiwand
AU - Jegarajah, Vinojaa
AU - Dal Bello, Riccardo
AU - Christ, Sebastian M
AU - Mayinger, Michael M
AU - Sabrina Stark, Luisa
AU - Willmann, Jonas
AU - Vogelius, Ivan R
AU - Balermpas, Panagiotis
AU - Andratschke, Nicolaus
AU - Tanadini-Lang, Stephanie
AU - Guckenberger, Matthias
N1 - © 2023 The Author(s).
PY - 2024/3
Y1 - 2024/3
N2 - •Stereotactic body radiation therapy (SBRT) for ultra-central lung tumors is associated with high toxicity rates.•To evaluate differences in radiosensitivity within the proximal bronchial tree (PBT), the PBT was sub-segmented into seven anatomical sections.•A risk-adapted SBRT regimen of EQD2_10 = 54.4 Gy in 8 or 10 fractions results in excellent local control and low rates of severe toxicity.•Data from a recent meta-analysis, the NORDIC Hilus trial and dosimetric data from this study were combined to create a NTCP model.•A dose threshold of EQD2_3 = 100 Gy to the PBT or any of its subsegments is expected to result in low rates of severe bronchial toxicity.
AB - •Stereotactic body radiation therapy (SBRT) for ultra-central lung tumors is associated with high toxicity rates.•To evaluate differences in radiosensitivity within the proximal bronchial tree (PBT), the PBT was sub-segmented into seven anatomical sections.•A risk-adapted SBRT regimen of EQD2_10 = 54.4 Gy in 8 or 10 fractions results in excellent local control and low rates of severe toxicity.•Data from a recent meta-analysis, the NORDIC Hilus trial and dosimetric data from this study were combined to create a NTCP model.•A dose threshold of EQD2_3 = 100 Gy to the PBT or any of its subsegments is expected to result in low rates of severe bronchial toxicity.
UR - http://www.scopus.com/inward/record.url?scp=85180517931&partnerID=8YFLogxK
U2 - 10.1016/j.ctro.2023.100707
DO - 10.1016/j.ctro.2023.100707
M3 - Journal article
C2 - 38125648
SN - 2405-6308
VL - 45
JO - Clinical and Translational Radiation Oncology
JF - Clinical and Translational Radiation Oncology
M1 - 100707
ER -